Author:
Kulkarni Anjali,Dogra Nupur,Zigras Tiffany
Abstract
Primary vaginal cancer is a rare gynecologic malignancy. Given the rarity of the disease, standardized approaches to management are limited, and a great variety of therapeutic conditions are endorsed. This paper reviews advances in surgical approaches, radiation, chemoradiation, and immunotherapy. Advances in surgical management including the increasing use of laparoscopic and endoscopic approaches, as well as the novel techniques in vaginal reconstruction, are reviewed. Concurrent chemoradiation remains a mainstay of treatment for vaginal cancer and has improved local control of disease and overall survival. Additionally, with metastatic disease or situations where toxicity from CCRT is unacceptable, systemic therapies including immunotherapy approaches are reviewed.
Reference53 articles.
1. Cancer of the vagina: 2021 update
2. Canadian Cancer Society
https://cancer.ca/en/cancer-information/cancer-types/vaginal/statistics
3. Vaginal cancer
4. Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes
5. Key Statistics for Vaginal Cancer
https://www.cancer.org/cancer/vaginal-cancer/about/key-statistics.html#written_by
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献